Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (annual application deadline, projected)
Funding Amounts: Funding levels not specified; details provided via initiative page or by inquiry.
Summary: Supports hepatitis C screening, harm reduction, and healthcare infrastructure projects in five Appalachian states affected by the opioid crisis.
Key Information: Eligibility and funding details may vary; check the initiative page for the latest requirements.